Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05540626 · ClinicalTrials.gov registry record · NA
RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor
A NA study, sponsored by Cala Health.
- Completed
- Registry status
- NA
- Development phase
- 276
- Enrollment target
NCT05540626 is a NA study that has completed, run by Cala Health. The registered enrollment target is 276 participants.
The verdict
NCT05540626, a NA study, has completed, sponsored by Cala Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
Study Summary
The study objective is to evaluate hand tremor relief in the treated hand following stimulation with the Cala Trio Device in adults with essential tremor, and healthcare resource utilization and total healthcare costs over a 12-month period.
Interventions
- DEVICE Cala Trio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2021-04-08 |
| Est. Completion | 2024-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05540626
The ClinicalTrials.gov registry entry for NCT05540626 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cala Health, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cala Trio is the first listed.
NCT05540626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05540626 about?
NCT05540626 is a clinical study titled "RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor". The study objective is to evaluate hand tremor relief in the treated hand following stimulation with the Cala Trio Device in adults with essential tremor, and healthcare resource utilization and total healthcare costs over a 12-month period.
What is the current status of trial NCT05540626?
This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2021-04-08. Estimated completion is 2024-03-01.
What interventions are being tested in trial NCT05540626?
The interventions under investigation include: Cala Trio (DEVICE).
Who is sponsoring clinical trial NCT05540626?
This trial is sponsored by Cala Health, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.